Episode 77
Biotech Hangout
00:00
New Valent's Success and Future Plans
This chapter explores New Valent's recent success in raising $300 million and their data presented at the triple meeting. They discuss their focus on developing targeted therapies for cancer patients, specifically highlighting their program for alk non-small cell lung cancer. The chapter concludes with an overview of their ongoing phase one-two study and the positive results they have observed so far.
Transcript
Play full episode
